FILTER

Refine your search with the following facets to narrow down your results.

4 Current news of ElexoPharm

ElexoPharm Receives € 2.1 Million EUROSTARS Grant

23-May-2012 - A EUROSTARS grant of €2.1 million has been awarded to a transnational consortium consisting of Khondrion BV ( Nijmegen), Radboud University Nijmegen Medical Centre (RUNMC, Nijmegen), Pharmacelsus GmbH (Saarbruecken) and ElexoPharm GmbH (Saarbruecken). This grant, which for the German partners ...

mitochondrial diseases

ElexoPharm Appoints Dr. Chris J. van Koppen as Head of Research

20-Apr-2012 - ElexoPharm GmbH announces the appointment of Dr. Chris J. van Koppen as Head of Research. He will lead the preclinical drug discovery projects of ElexoPharm and will build further alliances with larger pharmaceutical companies. Dr. van Koppen holds a Ph.D. in Pharmacology and brings extensive ...

ElexoPharm Appoints Prof. Jürgen Engel as Chairman of the Advisory Board

27-May-2010 - ElexoPharm GmbH announced the appointment of Professor Dr. Jürgen Engel as Chairman of its Advisory Board. He is going to support ElexoPharm’s efforts to expand its activities in preclinical drug development and to build up strong alliances with big pharmaceutical companies. As Chairman of the ...

drug development Germany Pharmaceutics

Elexopharm Enters Into Cardiovascular Collaboration With Merck & Co., Inc

18-May-2010 - ElexoPharm GmbH announced a collaboration and exclusive worldwide license agreement with Merck & Co., Inc. through an affiliate to develop and commercialize novel candidates targeting aldosterone synthase for the potential treatment of cardiovascular disease. Under the terms of the agreement, ...

cardiovascular diseases license agreements Merck